tiprankstipranks
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
US Market
ZLDPF
Zealand Pharma
RESEARCH TOOLSreports

Zealand Pharma (ZLDPF) Income Statement

194 Followers

Zealand Pharma Income Statement

Last quarter (Q4 2025), Zealand Pharma's total revenue was kr68.92M, an increase of 660.99% from the same quarter last year. In Q4, Zealand Pharma's net income was kr-379.12M. See Zealand Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 9.21Bkr 62.69Mkr 342.79Mkr 103.99Mkr 292.57M
Gross Profit
kr 9.19Bkr 54.82Mkr 323.61Mkr 73.28Mkr 173.75M
Operating Expenses
kr 2.03Bkr 1.33Bkr 895.85Mkr 920.59Mkr 1.22B
Depreciation and Amortization
kr 27.37Mkr 25.85Mkr 25.09Mkr 30.71Mkr 25.12M
EBITDA
kr 7.18Bkr -1.02Bkr -651.58Mkr -884.88Mkr -729.68M
Operating Income
kr 7.16Bkr -1.27Bkr -572.24Mkr -816.60Mkr -1.05B
Other Income/Expenses
kr -154.79Mkr 188.76Mkr -136.63Mkr -134.89Mkr 25.43M
Pretax Income
kr 7.00Bkr -1.08Bkr -708.87Mkr -972.04Mkr -1.03B
Net Income
kr 6.46Bkr -1.08Bkr -703.74Mkr -965.61Mkr -1.02B
Per Share Metrics
Basic EPS
kr 91.56kr -16.24kr -12.44kr -20.90kr -23.75
Diluted EPS
kr 90.22kr -16.24kr -12.44kr -20.90kr -23.75
Weighted Average Shares Outstanding
 70.50M 66.43M 56.59M 46.20M 42.87M
Weighted Average Shares Outstanding (Diluted)
 71.55M 66.43M 56.59M 46.20M 42.87M
Currency in DKK

Zealand Pharma Earnings and Revenue History